PMC:7195088 / 68530-68801 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1991","span":{"begin":90,"end":98},"obj":"Species"},{"id":"1992","span":{"begin":224,"end":232},"obj":"Species"},{"id":"1998","span":{"begin":260,"end":269},"obj":"Species"},{"id":"2000","span":{"begin":198,"end":209},"obj":"Chemical"},{"id":"2006","span":{"begin":104,"end":124},"obj":"Disease"}],"attributes":[{"id":"A1991","pred":"tao:has_database_id","subj":"1991","obj":"Tax:9606"},{"id":"A1992","pred":"tao:has_database_id","subj":"1992","obj":"Tax:9606"},{"id":"A1998","pred":"tao:has_database_id","subj":"1998","obj":"Tax:11520"},{"id":"A2000","pred":"tao:has_database_id","subj":"2000","obj":"MESH:D053139"},{"id":"A2006","pred":"tao:has_database_id","subj":"2006","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Pending further evidence, in our opinion, antiviral treatments should not be initiated in patients with SARS-CoV-2 infection outside RCT or compassionate-use programmes (with the exception of early oseltamivir initiation in patients with suspected concomitant influenza)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T386","span":{"begin":104,"end":112},"obj":"Disease"},{"id":"T387","span":{"begin":115,"end":124},"obj":"Disease"},{"id":"T388","span":{"begin":260,"end":269},"obj":"Disease"}],"attributes":[{"id":"A386","pred":"mondo_id","subj":"T386","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A387","pred":"mondo_id","subj":"T387","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A388","pred":"mondo_id","subj":"T388","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"}],"text":"Pending further evidence, in our opinion, antiviral treatments should not be initiated in patients with SARS-CoV-2 infection outside RCT or compassionate-use programmes (with the exception of early oseltamivir initiation in patients with suspected concomitant influenza)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3796","span":{"begin":42,"end":51},"obj":"Chemical"},{"id":"T49322","span":{"begin":198,"end":209},"obj":"Chemical"}],"attributes":[{"id":"A4643","pred":"chebi_id","subj":"T3796","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A90307","pred":"chebi_id","subj":"T49322","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"}],"text":"Pending further evidence, in our opinion, antiviral treatments should not be initiated in patients with SARS-CoV-2 infection outside RCT or compassionate-use programmes (with the exception of early oseltamivir initiation in patients with suspected concomitant influenza)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T479","span":{"begin":0,"end":271},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Pending further evidence, in our opinion, antiviral treatments should not be initiated in patients with SARS-CoV-2 infection outside RCT or compassionate-use programmes (with the exception of early oseltamivir initiation in patients with suspected concomitant influenza)."}